| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9253888 | Journal of Hepatology | 2005 | 6 Pages |
Abstract
These findings suggest that the combination of PEI or RFTA and active antigen specific immunotherapeutic approaches using DCs is a promising approach for the induction of sustained antitumoral immune responses aiming at the reduction of tumor recurrence and metastases in HCC patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Mona Y. Ali, Christian F. Grimm, Marcus Ritter, Leonhard Mohr, Hans-Peter Allgaier, Robert Weth, Wulf O. Bocher, Katja Endrulat, Hubert E. Blum, Michael Geissler,